ArticleBreast cancer (Tokyo, Japan)2024

Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer.

Sae Kitano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.